The platelet receptors for fibrinogen and von Willebrand factor play a central role in platelet physiology since adhesion to non-collagenous surfaces and aggregation induced by ristocetin or any of the agonists that are thought to act in vivo require the binding of one or the other of these proteins to their receptor(s) on the platelet surface. This proposal aims to: 1) improve our understanding of the biochemistry and physiology of these receptors by employing the murine monoclonal antibodies that the principle investigator made during the previous grant period that block the binding of these proteins to their receptor(s) and 2) prepare additional antibodies against other platelet receptors. Specific experiments will be directed at: 1) deciding the potential therapeutic usefullness of the antibodies in treating thrombotic disease by studies in animal models and pilot studies in humans, 2) applying the anti-GPIIb/IIIa antibody to carrier detection of thrombasthenia in a population (Iraqi-Jewish) with a high frequency of the gene, 3) discovering the precursors of GPIb, GPIIb and GPIIIa that are present in megakaryocytes, 4) characterizing the relationship between GPIb and the Mr 20,000 glycoprotein that copurifies with it, 5) evaluating whether glycocalicin circulates in plasma, 6) investigating whether GPIIb and GPIIIa exist as hetero-complexes in unactivated platelets, 7) defining whether the glycoproteins are transmembrane and whether they have free sulfhydryl groups, 8) determining the role of the different glycoproteins in binding von Willebrand factor when platelets are stimulated with various agonists, 9) assessing whether thrombospondin binds to a receptor on activated platelets separate from fibrinogen, 10) using fluorescence resonance energy transfer to determine whether GPIIb/IIIa and GPIb form homo- and/or hetero-clusters during platelet activation, and 11) employing a sensitive and specific assay for factor X activation to assess whether functionally significant factor VIII:C gains access to the platelet by being in complex with von Willebrand factor when the latter binds to platelets. These studies thus combine attempts to apply our present knowledge to clinical practice with the generation of new basic knowledge from which additional clinical applications may derive.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL019278-13
Application #
3335772
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1976-09-01
Project End
1989-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
13
Fiscal Year
1988
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Mancini, Donna; Monteagudo, Juan; Suárez-Fariñas, Mayte et al. (2018) New methodologies to accurately assess circulating active transforming growth factor-?1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices. Transl Res 192:15-29
Zafar, Hina; Shang, Yi; Li, Jihong et al. (2017) ?IIb?3 binding to a fibrinogen fragment lacking the ?-chain dodecapeptide is activation dependent and EDTA inducible. Blood Adv 1:417-428
Wang, Wei; Burg, Nathalie; Vootukuri, Spandana et al. (2016) Increased Smad2/3 phosphorylation in circulating leukocytes and platelet-leukocyte aggregates in a mouse model of aortic valve stenosis: Evidence of systemic activation of platelet-derived TGF-?1 and correlation with cardiac dysfunction. Blood Cells Mol Dis 58:1-5
Buitrago, Lorena; Rendon, Augusto; Liang, Yupu et al. (2015) ?IIb?3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia. Proc Natl Acad Sci U S A 112:E1898-907
Coller, Barry S (2015) Blood at 70: its roots in the history of hematology and its birth. Blood 126:2548-60
Coller, B S (2015) ?IIb?3: structure and function. J Thromb Haemost 13 Suppl 1:S17-25
Jiang, Jian-kang; McCoy, Joshua G; Shen, Min et al. (2014) A novel class of ion displacement ligands as antagonists of the ?IIb?3 receptor that limit conformational reorganization of the receptor. Bioorg Med Chem Lett 24:1148-53
Li, Jihong; Vootukuri, Spandana; Shang, Yi et al. (2014) RUC-4: a novel ?IIb?3 antagonist for prehospital therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 34:2321-9
Provasi, Davide; Negri, Ana; Coller, Barry S et al. (2014) Talin-driven inside-out activation mechanism of platelet ?IIb?3 integrin probed by multimicrosecond, all-atom molecular dynamics simulations. Proteins 82:3231-3240
Wang, Wei; Vootukuri, Spandana; Meyer, Alexander et al. (2014) Association between shear stress and platelet-derived transforming growth factor-?1 release and activation in animal models of aortic valve stenosis. Arterioscler Thromb Vasc Biol 34:1924-32

Showing the most recent 10 out of 70 publications